Abstract:BACKGROUND:Lung function measures reflect the physiological state of the lung, and are essential to the diagnosis of chronic obstructive pulmonary disease (COPD). The SpiroMeta-CHARGE consortium undertook the largest genome-wide association study (GWAS) so far (n=48,201) for forced expiratory volume in 1 s (FEV1) and the ratio of FEV1 to forced vital capacity (FEV1/FVC) in the general population. The lung expression quantitative trait loci (eQTLs) study mapped the genetic architecture of gene expression in lung tissue from 1111 individuals. We used a systems genetics approach to identify single nucleotide polymorphisms (SNPs) associated with lung function that act as eQTLs and change the level of expression of their target genes in lung tissue; termed eSNPs. METHODS:The SpiroMeta-CHARGE GWAS results were integrated with lung eQTLs to map eSNPs and the genes and pathways underlying the associations in lung tissue. For comparison, a similar analysis was done in peripheral blood. The lung mRNA expression levels of the eSNP-regulated genes were tested for associations with lung function measures in 727 individuals. Additional analyses identified the pleiotropic effects of eSNPs from the published GWAS catalogue, and mapped enrichment in regulatory regions from the ENCODE project. Finally, the Connectivity Map database was used to identify potential therapeutics in silico that could reverse the COPD lung tissue gene signature. FINDINGS:SNPs associated with lung function measures were more likely to be eQTLs and vice versa. The integration mapped the specific genes underlying the GWAS signals in lung tissue. The eSNP-regulated genes were enriched for developmental and inflammatory pathways; by comparison, SNPs associated with lung function that were eQTLs in blood, but not in lung, were only involved in inflammatory pathways. Lung function eSNPs were enriched for regulatory elements and were over-represented among genes showing differential expression during fetal lung development. An mRNA gene expression signature for COPD was identified in lung tissue and compared with the Connectivity Map. This in-silico drug repurposing approach suggested several compounds that reverse the COPD gene expression signature, including a nicotine receptor antagonist. These findings represent novel therapeutic pathways for COPD. INTERPRETATION:The system genetics approach identified lung tissue genes driving the variation in lung function and susceptibility to COPD. The identification of these genes and the pathways in which they are enriched is essential to understand the pathophysiology of airway obstruction and to identify novel therapeutic targets and biomarkers for COPD, including drugs that reverse the COPD gene signature in silico. FUNDING:The research reported in this article was not specifically funded by any agency. See Acknowledgments for a full list of funders of the lung eQTL study and the Spiro-Meta CHARGE GWAS.

Airway Epithelial Expression Quantitative Trait Loci Reveal Genes Underlying Asthma and Other Airway Diseases

Lung Eqtls to Help Reveal the Molecular Underpinnings of Asthma.

SNPs Identified by GWAS Affect Asthma Risk Through DNA Methylation and Expression of Cis-Genes in Nasal (airway) Epithelium

Functional characterization of eQTLs and asthma risk loci with scATAC-seq across immune cell types and contexts

De novo identification of complex traits associated with asthma

Integrated genomics analysis highlights important SNPs and genes implicated in moderate-to-severe asthma based on GWAS and eQTL datasets

Identification of asthma-related genes using asthmatic blood eQTLs of Korean patients

Dynamic responses of human lung innate and adaptive immune cells highlight the roles of genes at asthma risk loci

Cis - and trans -eQTM analysis reveals novel epigenetic and transcriptomic immune markers of atopic asthma in airway epithelium

A multi-omics Mendelian randomization identifies putatively causal genes and DNA methylation sites for asthma

Prioritization of candidate causal genes in GWAS signals of asthma in UK Biobank

A cellular census of healthy lung and asthmatic airway wall identifies novel cell states in health and disease

Lipid Metabolism-Related Genes Are Involved in the Occurrence of Asthma and Regulate the Immune Microenvironment

Polymorphisms in the airway epithelium related genes CDHR3 and EMSY are associated with asthma susceptibility

Genetic Regulation of Gene Expression in the Lung Identifiescst3andcd22as Potential Causal Genes for Airflow Obstruction

Uncovering Potential Key Genes Associated with the Pathogenesis of Asthma: A Microarray Analysis of Asthma-Relevant Tissues

Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank

Weighted gene co-expression network analysis reveals key biomarkers and immune infiltration characteristics for bronchial epithelial cells from asthmatic patients

Shared genetic aetiology of respiratory diseases: a genome-wide multitraits association analysis

Cell-type-specific and disease-associated expression quantitative trait loci in the human lung

Molecular mechanisms underlying variations in lung function: a systems genetics analysis